You are here

  • Home
  • Online First
  • Natriuretic peptides, extracellular volume, and subclinical cardiovascular changes in chronic kidney disease stages 1–3: a pilot study

Article info

Article menu
Download PDFPDF
Original research
Natriuretic peptides, extracellular volume, and subclinical cardiovascular changes in chronic kidney disease stages 1–3: a pilot study

Authors

  • L Parker Gregg Selzman Institute for Kidney Health, Section of Nephrology, Department of Medicine, Baylor College of Medicine, Houston, Texas, USAMedical Care Line, Section of Nephrology, Michael E DeBakey Veterans Affairs Medical Center, Houston, Texas, USAVeterans Affairs Health Services Research and Development Center for Innovations in Quality, Effectiveness and Safety, Houston, Texas, USA PubMed articlesGoogle scholar articles
  • Peter N Van Buren Internal Medicine, Division of Nephrology, University of Texas Southwestern Medical Center, Dallas, Texas, USAMedical Service, Renal Section, Veterans Affairs North Texas Health Care System, Dallas, Texas, USA PubMed articlesGoogle scholar articles
  • David J Ramsey Veterans Affairs Health Services Research and Development Center for Innovations in Quality, Effectiveness and Safety, Houston, Texas, USA PubMed articlesGoogle scholar articles
  • Amaris Maydon Mental Health Service, Veterans Affairs North Texas Health Care System, Dallas, Texas, USA PubMed articlesGoogle scholar articles
  • Subhash Banerjee Internal Medicine, Division of Cardiology, University of Texas Southwestern Medical Center, Dallas, Texas, USAMedical Service, Cardiology Section, Veterans Affairs North Texas Health Care System, Dallas, Texas, USA PubMed articlesGoogle scholar articles
  • Carl P Walther Selzman Institute for Kidney Health, Section of Nephrology, Department of Medicine, Baylor College of Medicine, Houston, Texas, USA PubMed articlesGoogle scholar articles
  • Salim S Virani Veterans Affairs Health Services Research and Development Center for Innovations in Quality, Effectiveness and Safety, Houston, Texas, USAInternal Medicine, Section of Cardiology, Baylor College of Medicine, Houston, Texas, USAInternal Medicine, Section of Cardiology, Michael E. DeBakey Veterans Affairs Medical Center, Houston, Texas, USA PubMed articlesGoogle scholar articles
  • Wolfgang C Winkelmayer Selzman Institute for Kidney Health, Section of Nephrology, Department of Medicine, Baylor College of Medicine, Houston, Texas, USA PubMed articlesGoogle scholar articles
  • Sankar D Navaneethan Selzman Institute for Kidney Health, Section of Nephrology, Department of Medicine, Baylor College of Medicine, Houston, Texas, USAMedical Care Line, Section of Nephrology, Michael E DeBakey Veterans Affairs Medical Center, Houston, Texas, USAVeterans Affairs Health Services Research and Development Center for Innovations in Quality, Effectiveness and Safety, Houston, Texas, USAInstitute of Clinical and Translational Research, Baylor College of Medicine, Houston, Texas, USA PubMed articlesGoogle scholar articles
  • S Susan Hedayati Internal Medicine, Division of Nephrology, University of Texas Southwestern Medical Center, Dallas, Texas, USA PubMed articlesGoogle scholar articles
  1. Correspondence to Dr L Parker Gregg, Baylor College of Medicine Department of Medicine, Houston, Texas, USA; lucile.gregg{at}bcm.edu
View Full Text

Citation

Gregg LP, Van Buren PN, Ramsey DJ, et al
Natriuretic peptides, extracellular volume, and subclinical cardiovascular changes in chronic kidney disease stages 1–3: a pilot study
Journal of Investigative Medicine Published Online First: 19 July 2022. doi: 10.1136/jim-2022-002467

Publication history

  • Accepted June 1, 2022
  • First published July 19, 2022.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

The interpretation and reporting of these data are the responsibility of the authors and in no way should be viewed as official policy or interpretation of the Department of Veterans Affairs or the US government.Peter Van Buren is an Associate Editor; please add the disclosure to the competing interests statement.Final comment from a reviewer (please check with the authors at the galley stage):"In discussion there is just a sentence with typo that needs fixing: "Our exploratory results generate hypotheses that subclinical changes in cardiovascular parameters that may exist in patients with CKD stages 1-3."I believe extra word "that" should be removed."